185 related articles for article (PubMed ID: 32243396)
1. The association of hepatitis B virus screening and antiviral prophylaxis with adverse liver outcomes in Chinese cancer patients undergoing chemotherapy: A retrospective study.
He LY; Wang YL; Tian X; Chen WQ
Medicine (Baltimore); 2020 Apr; 99(14):e19647. PubMed ID: 32243396
[TBL] [Abstract][Full Text] [Related]
2. Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy.
Hwang JP; Suarez-Almazor ME; Cantor SB; Barbo A; Lin HY; Ahmed S; Chavez-MacGregor M; Donato-Santana C; Eng C; Ferrajoli A; Fisch MJ; McLaughlin P; Simon GR; Rondon G; Shpall EJ; Lok AS
Cancer; 2017 Sep; 123(17):3367-3376. PubMed ID: 28518219
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive outcomes of on- and off-antiviral prophylaxis in hepatitis B patients undergoing cancer chemotherapy: A competing risks analysis.
An J; Shim JH; Kim SO; Choi J; Kim SW; Lee D; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
J Med Virol; 2016 Sep; 88(9):1576-86. PubMed ID: 26945543
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update.
Hwang JP; Feld JJ; Hammond SP; Wang SH; Alston-Johnson DE; Cryer DR; Hershman DL; Loehrer AP; Sabichi AL; Symington BE; Terrault N; Wong ML; Somerfield MR; Artz AS
J Clin Oncol; 2020 Nov; 38(31):3698-3715. PubMed ID: 32716741
[TBL] [Abstract][Full Text] [Related]
5. Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration.
Hunt CM; Beste LA; Lowy E; Suzuki A; Moylan CA; Tillmann HL; Ioannou GN; Lim JK; Kelley MJ; Provenzale D
World J Gastroenterol; 2016 May; 22(19):4732-40. PubMed ID: 27217704
[TBL] [Abstract][Full Text] [Related]
6. Testing for hepatitis B infection in prospective chemotherapy patients: a retrospective study.
Wang Y; Luo XM; Yang D; Zhang J; Zhuo HY; Zhang J; Jiang Y
World J Gastroenterol; 2013 Feb; 19(6):923-30. PubMed ID: 23429298
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus screening and reactivation and management of patients with nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis from an endemic area.
Lv JW; Chen YP; Huang XD; Zhou GQ; Chen L; Li WF; Tang LL; Mao YP; Guo Y; Xu RH; Ma J; Sun Y
Cancer; 2017 Sep; 123(18):3540-3549. PubMed ID: 28493307
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B Virus Screening and Real Life Data in Patients with Solid Tumor Receiving Chemotherapy.
Fidan S; Fidan E; Alandağ C; Erkut M; Cosar AM
Arch Iran Med; 2020 Dec; 23(12):835-841. PubMed ID: 33356341
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy: a real-life experience.
Papadopoulos N; Deutsch M; Manolakopoulos S; Bitsi C; Michalakeas H; Poulakidas H; Tsironi E; Giannouli S; Papatheodoridis GV; Koskinas J; Pectasides D
Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):56-60. PubMed ID: 27669175
[TBL] [Abstract][Full Text] [Related]
10. Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: A meta-analysis.
Paul S; Dickstein A; Saxena A; Terrin N; Viveiros K; Balk EM; Wong JB
Hepatology; 2017 Aug; 66(2):379-388. PubMed ID: 28128861
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients.
Liao YP; Jiang JL; Zou WY; Xu DR; Li J
World J Gastroenterol; 2015 Apr; 21(14):4284-92. PubMed ID: 25892880
[TBL] [Abstract][Full Text] [Related]
12. Baseline HBV load increases the risk of anti-tuberculous drug-induced hepatitis flares in patients with tuberculosis.
Zhu CH; Zhao MZ; Chen G; Qi JY; Song JX; Ning Q; Xu D
J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):105-109. PubMed ID: 28224437
[TBL] [Abstract][Full Text] [Related]
13. Influence of chronic HBV infection on superimposed acute hepatitis E.
Cheng SH; Mai L; Zhu FQ; Pan XF; Sun HX; Cao H; Shu X; Ke WM; Li G; Xu QH
World J Gastroenterol; 2013 Sep; 19(35):5904-9. PubMed ID: 24124337
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus management to prevent reactivation after chemotherapy: a review.
Hwang JP; Vierling JM; Zelenetz AD; Lackey SC; Loomba R
Support Care Cancer; 2012 Nov; 20(11):2999-3008. PubMed ID: 22933131
[TBL] [Abstract][Full Text] [Related]
15. Scoring system for risk stratification of viral reactivation during prophylactic antiviral treatment in Korean patients with hepatitis B undergoing anticancer chemotherapy: A multicenter study.
Kim HY; Yoo JJ; Oh S; Yu SJ; Kim YJ; Yoon JH; Kim W; Jung YJ; Kim BH; Kim CM; Park JW; Lee JH
J Med Virol; 2018 Oct; 90(10):1593-1603. PubMed ID: 29900560
[TBL] [Abstract][Full Text] [Related]
16. Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease.
Chen FW; Coyle L; Jones BE; Pattullo V
Liver Int; 2013 Sep; 33(8):1203-10. PubMed ID: 23522150
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic antiviral treatment reduces the incidence of liver failure among patients coinfected with Mycobacterium tuberculosis and hepatitis B virus.
Lian J; Hu P; Lu Y; Liu Y; Wang X; Zhang Y; Jia H; Yang Y
Virus Res; 2019 Sep; 270():197664. PubMed ID: 31315023
[TBL] [Abstract][Full Text] [Related]
18. Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy.
Law MF; Ho R; Cheung CK; Tam LH; Ma K; So KC; Ip B; So J; Lai J; Ng J; Tam TH
World J Gastroenterol; 2016 Jul; 22(28):6484-500. PubMed ID: 27605883
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis against hepatitis B virus recurrence after liver transplantation: a registry study.
Shen S; Jiang L; Xiao GQ; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Xu MQ; Wei YG
World J Gastroenterol; 2015 Jan; 21(2):584-92. PubMed ID: 25593480
[TBL] [Abstract][Full Text] [Related]
20. Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
Huang H; Li X; Zhu J; Ye S; Zhang H; Wang W; Wu X; Peng J; Xu B; Lin Y; Cao Y; Li H; Lin S; Liu Q; Lin T
JAMA; 2014 Dec; 312(23):2521-30. PubMed ID: 25514302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]